GENOSS CO., LTD.

Since established in 2004, Genoss have expanded the products category to Vascular Intervention, Aesthetic, Cosmetic, Dental Biomaterials, Medical Devices and Orthopedic Devices. We have global network more than 55 countries, including Germany, Mexico, America, Iran and China, and supply our products to a lot of prestigious clients and institutions. Our annual revenue was 54.5 billion dollars in 2024 and we are continuously growing company. Especially, we invest 20% of our annual revenue in R&D, showing our commitment to research-driven manufacturing and innovations.
< DES >
Sirolimus Eluting Coronary Stent System
• Thin 70 μm strut thickness
• Excellent support with an S-shaped design
• Outstanding clinical results
- Specification:
Nominal Pressure: 9 atm (2.25 ~ 3.50 mm), 10 atm (3.75 ~ 4.00 mm)
Rated Burst Pressure: 16 atm (2.25 ~ 3.50 mm), 14 atm (3.75 ~ 4.00 mm)

< Lidocaine Filler >
Monalisa High Elastic [Particle size: 600μm / 900μm]
• Long-lasting volumizing effect
• Customized formulas tailored to individual needs
• Premium, highly pure hyaluronic acid with lidocaine
Monalisa Lidocaine [Particle size: 200μm / 400μm / 600μm / 900μm]
• Volumizing effect and retention
• Formulations for different cosmetic needs
• Highly pure hyaluronic acid with lidocaine

< 3d Cage (Cervical/Lumbar) >
Cervical [Single Angled / Double Angled / Wing Type]
• For Cervical DDD - therapeutic application
• Multiple Shapes - patient-specific options
• Fast Fusion - strong mechanical stability
Lumbar
• PLIF: 0–15° Hyper Lordotic Angles, Rounded Profile, Rounded Entry Form
• ALIF: Easy-Locking System, 0–30° Hyper Lordotic Angles
• OLIF: Protective Entry Shape, 0°/20° Coupling